CIK 0001850270 · <br>Emerging growth company
PROKIDNEY CORP.
Sign in to watch- Ticker
- PROK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- EIN
- 981586514
- Phone
- 336-999-7028
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
- Former names
- Social Capital Suvretta Holdings Corp. III
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,067,773
- in 1 filing
Net −$1,067,773. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-11 | Control Empresarial de Capitales S.A. de C.V. 10% owner | Purchase | +8,264,462 | $2.42 | $20.0M | 71,560,107 |
| 2024-05-30 | Fox Jennifer A. Director | Grant or award · Director stock option (right to buy) | +62,558 | 62,558 | ||
| 2024-05-30 | Sinha Uma Director | Grant or award · Director stock option (right to buy) | +62,558 | 62,558 | ||
| 2024-05-30 | Legorreta Pablo G. Director | Grant or award · Director stock option (right to buy) | +62,558 | 62,558 | ||
| 2024-05-30 | Pereira Brian JG Director | Grant or award · Director stock option (right to buy) | +62,558 | 62,558 | ||
| 2024-05-30 | Jimenez Santos Jose Ignacio Director | Grant or award · Director stock option (right to buy) | +62,558 | 62,558 | ||
| 2024-05-30 | DOYLE WILLIAM F Director | Grant or award · Director stock option (right to buy) | +62,558 | 62,558 | ||
| 2024-05-30 | Lotvin Alan Director | Grant or award · Director stock option (right to buy) | +62,558 | 62,558 | ||
| 2024-05-20 | Weber Darin J. Chief Regulatory Officer | Sale 10b5-1 | −17,238 | $4.08 | $70K | 137,956 |
| 2024-04-22 | Weber Darin J. SVP of Regulatory Development | Sale 10b5-1 | −16,438 | $2.51 | $41K | 155,194 |
| 2024-04-18 | Weber Darin J. SVP of Regulatory Development | Sale 10b5-1 | −800 | $2.54 | $2K | 171,632 |
| 2024-04-16 | Weber Darin J. SVP of Regulatory Development | Sale 10b5-1 | −17,238 | $2.50 | $43K | 172,432 |
| 2024-04-12 | Weber Darin J. SVP of Regulatory Development | Sale 10b5-1 | −84,103 | $1.73 | $145K | 189,670 |
| 2024-04-01 | Weber Darin J. SVP of Regulatory Development | Sale 10b5-1 | −300 | $1.69 | $507 | 273,773 |
| 2024-04-01 | Ernst Ulrich Peter Alfred EVP, Technical Operations | Grant or award · Employee stock option (right to buy) | +335,000 | 335,000 | ||
| 2024-03-25 | Control Empresarial de Capitales S.A. de C.V. 10% owner | Purchase | +30,000 | $1.43 | $43K | 63,295,645 |
| 2024-03-22 | Control Empresarial de Capitales S.A. de C.V. 10% owner | Purchase | +14,000 | $1.40 | $20K | 63,265,645 |
| 2024-03-20 | Control Empresarial de Capitales S.A. de C.V. 10% owner | Purchase | +33,000 | $1.40 | $46K | 63,251,645 |
| 2024-03-14 | Control Empresarial de Capitales S.A. de C.V. 10% owner | Purchase | +50,000 | $1.36 | $68K | 63,218,645 |
| 2024-03-13 | Control Empresarial de Capitales S.A. de C.V. 10% owner | Purchase | +50,000 | $1.50 | $75K | 63,168,645 |
Page 5 of 12 · 231 trades